http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddb92bbd2103e2a9d323d8e5df28d3dd
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Giordano |
| name | Antonio Giordano |
| given-name | Antonio |
| organization-name | Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA; Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Medical Oncology, Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA Institute of Normal Human Morphology, Faculty of Medicine, University of Ancona, Italy Sbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology; College of Science and Technology Temple University; Philadelphia Pennsylvania; Department of Human Pathology and Oncology; University of Siena; Siena Italy Institute of Normal Human Morphology, School of Medicine, Marche Polytechnic University, Via Tronto, 10/A, 60020 Ancona, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University BioLife Science, Philadelphia, PA 19122, USA. Institute of Normal Human Morphology, Marche Polytechnic University, Ancona, Italy Internal Medicine II and Stroke Unit Sbarro Health Research Organization, Philadelphia, PA, USA; Deparment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy 1 Institute of Normal Human Morphology Sbarro Research Institute College of Science and Technology Temple University Philadelphia Pennsylvania USA; Department of Medicine Surgery & Neuroscience University of Siena Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology Temple University Philadelphia Pennsylvania Sbarro Institute for Research and Molecular Medicine and Department of Biology Temple University Philadelphia USA; Department of Biology Temple University Philadelphia Pennsylvania 1Sbarro Institute for Cancer Research and Molecular Medicine, Center of Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania;; 2Department of Human Pathology and Oncology, University of Siena, Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine Philadelphia Pennsylvania; Department of Biology College of Science and Technology, Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology, College of Science and Technology Temple University, Philadelphia, USA Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery, and Neuroscience, University of Siena, Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy 1Department of Biology, College of Science and Technology, Temple University, Sbarro Institute for Cancer Research and Molecular Medicine, Sbarro Institute for Cancer Research and Molecular MedicineCenter for BiotechnologyCollege of Science and TechnologyTemple University Philadelphia Pennsylvania USA; Department of Human Pathology and OncologyUniversity of Siena Siena Italy; CROM‐Center of Oncology Research Mercogliano Avellino Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA. giordano@temple.edu Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena and Istituto Toscano Tumori (ITT) Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine Temple University Philadelphia, Pennsylvania; Department of Biology College of Science and Technology, Temple University Philadelphia, Pennsylvania Unit of Digestive Disease, Campus Bio Medico University of Rome, Italy Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, College of Science and Technology, Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery and Neuroscience, “University of Siena”, Siena, Italy Dept. of Medicine, Surgery and Neurosciences, University of Siena, Italy; Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, USA Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA 19122, USA Department of Biology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania 19122, USA; Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania 19122, USA Sbarro Institute for Cancer Research and Molecular Medicine; Center for Biotechnology; College of Science and Technology; Temple University; Philadelphia Pennsylvania Oncology Research Center of Mercogliano (CROM) Istituto Nazionale per lo studio e la cura dei tumori “Fondazione Giovanni Pascale”‐IRCCS Naples Italy; Department of Medicine Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT) Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology Temple University Philadelphia Pennsylvania Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, 53100, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia PA, 19122, USA Department of Biology, College of Science and Technology, Temple University Philadelphia Pennsylvania; Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University Philadelphia Pennsylvania Department of Medicine, Medical University of South Carolina, Charleston, SC, USA Authors' Affiliations: Departments of 1Hematopathology and 2Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 3Biostatistics and Bioinformatics Facility, 4Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and Departments of 5Biostatistics and 6Medical Oncology, Institut Curie, Paris, France Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, Center for Biotechnology, College of Science and Technology, Temple University Philadelphia; Department of Medicine Surgery & Neuroscience, University of Siena Siena Italy Center for NeuroVirology and NeuroOncology, MCP Hahnemann University, Philadelphia, PA 19102; St. Christopher’s Hospital for Children, MCP Hahnemann University, Philadelphia, PA 19134; Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL 60153; and Sbarro Institute for Cancer Research, Department of Pathology, Thomas Jefferson University, Philadelphia, PA 19107 Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Thomas Jefferson University, and Sbarro Institute for Cancer Research and Molecular Medicine, Philadelphia, Pennsylvania, USA Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology Temple University Philadelphia Pennsylvania 1Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia; Department of Medicine Surgery and Neuroscience University of Siena Siena Italy; AORN Dei Colli Monaldi UOC Oncology Naples Italy; Sbarro Institute for Cancer Research and Molecular Medicine Center of Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Currently at Department of Medicine at Medical University of South Carolina, Charleston, SC, USA Department of Biotechnology, Temple University, Sbarro Foundation, Philadelphia, Pennsylvania, USA Dipartimento di Medicina Sperimentale e Clinica Center of Obesity Università Politecnica delle Marche Ancona Italy Authors' Affiliations: Departments of 1Hematopathology and 2Breast Medical Oncology, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, 3Department of Molecular Pathology and Metastasis Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas; 4Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II; 5Department of Breast Oncology, National Cancer Institute “Fondazione Pascale”, Naples, Italy; 6Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia; and 7Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Authors' Affiliations: Departments of 1Hematopathology and 2Breast Medical Oncology, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, 3Department of Molecular Pathology and Metastasis Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas; 4Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II; 5Department of Breast Oncology, National Cancer Institute “Fondazione Pascale”, Naples, Italy; 6Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia; and 7Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania Department of Medicine Surgery and Neuroscience University of Siena Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine Center of Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA, USA Sbarro Institute for Cancer Research and Molecular Medicine College of Science and Technology Temple University Philadelphia 19122 Pennsylvania; Department of Biology College of Science and Technology Temple University Philadelphia 19122 Pennsylvania; Department of Human Pathology and Oncology University of Siena Siena Italy Unit of Gastroenterology and Digestive Endoscopy, University Campus Bio Medico, Rome, Italy Sbarro Institute for Cancer Research and Molecular Medicine, Temple University Philadelphia, PA USA; Department of Human Pathology and Oncology, University of Siena, Nuovo Policlinico “Le Scotte”, Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine College of Science and Technology Temple University BioLife Science Bldg., 1900 N, 12th Street Philadelphia Pennsylvania; Oncology Research Center of Mercogliano (CROM) Istituto Nazionale Tumori “Fondazione Giovanni Pascale” IRCCS Naples Italy; Department of Medicine Surgery and Neuroscience University of Siena Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery & Neuroscience, University of Siena, Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology College of Science and Technology, Temple University, Philadelphia, PA, U.S.A. giordano@temple.edu. Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, College of Science and TechnologyTemple UniversityPhiladelphiaPennsylvania Department of Medical Biotechnologies University of Siena Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania Department of Human Pathology and Oncology, University of Siena, Siena, Italy; Sbarro Institute for Cancer Research & Molecular Medicine, Biolife Science Building Suite 333, Temple University Philadelphia, PA 19122, USA for the COVID-19 and Cancer Consortium Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, PA, USA Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology College of Science and Technology, Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy Thomas Jefferson University, Kimmel Cancer Institute, Department of Microbiology–Immunology and Molecular Neurovirology Section, Jefferson Institute of Molecular Medicine, Department of Biochemistry and Molecular Biology, Philadelphia, PA 19107; Laboratorio di Ematologia Oncologia Istituto Superiore di Sanita’, Rome, Italy; Istituto Regina Elena Centro Ricerca Sperimentale, Rome, Italy; and Ludwig Institute for Cancer Research, St. Mary’s Hospital Medical School, London W21PG, United Kingdom From the Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Università di Napoli “Federico II”; Dipartimento di Chirurgia Generale, Oncologica e Videoassistita, Università di Napoli “Federico II”, Napoli, Italy Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University BioLife Science, Philadelphia, PA, USA; Department of Medicine, Surgery & Neuroscience University of Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine Temple University Philadelphia Pennsylvania; Department of Biology, College of Science and Technology Temple University Philadelphia Pennsylvania Department of Medical Biotechnology University of Siena Siena Italy; Department of Biology, College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine Department of Biology, Center of Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania; Department of Medicine Surgery and Neuroscience University of Siena Siena Italy Department of Biology Center for Biotechnology, College of Science and Technology, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy Department of Molecular Pathology, Marche Polytechnic University, Ancona, Italy Department of Medicine, Surgery and Neuroscience; University of Siena; Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology; Temple University; Philadelphia Pennsylvania Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia PA, USA Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine Center of Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery, and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine e del Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, USA From the Departments of Medicine and Physiology, New York Medical College, Valhalla, NY; the Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY; and the Departments of Pathology, Anatomy, and Cell Biology and Institute for Cancer Research and Molecular Medicine, Jefferson Medical College, Philadelphia, Pa. 1Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology and; 3Department of Human Pathology and Oncology, University of Siena, Siena, Italy Institutes of Anatomy and Internal Medicine, School of Medicine, University of Ancona, Via Tronto 10/A, 60020 Ancona, Italy; Division of Endocrinology, Diabetes, and Metabolism, Harvard Medical School, 99 Brookline Avenue, Boston, MA 02215; Center for Study and Research on Obesity, Laboratorio Interdisciplinare Tecnologie Avanzate Vialba, Luigi Sacco Hospital, Via G. B. Grassi 74, 20157 Milan, Italy; and University of Medicine and Pharmacy, Stradã Petru Rares̊ 4, 200349 Craiova 1100, Romania Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States; Department of Biomedical Biotechnologies, University of Siena, Siena, Italy Department of Medicine, Surgery and Neuroscience; University of Siena and Istituto Toscano Tumori (ITT); Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine; Center for Biotechnology, College of Science and Technology, Temple University; Philadelphia Pennsylvania; Oncology Research Center of Mercogliano (CROM); Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione Giovanni Pascale” IRCCS; Naples Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Temple University, Philadelphia, PA, USA Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA; Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology; Temple University; Philadelphia, Pennsylvania Department of Experimental and Clinical Medicine and Center for the Study of Obesity, Marche Polytechnic University, Ancona, Italy. a.giordano@univpm.it. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery & Neuroscience, University of Siena, Siena, Italy Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, United States Department of Experimental and Clinical Medicine Marche Polytechnic University Ancona Italy Department of Biology Sbarro Institute for Cancer Research and Molecular Medicine Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine Center of Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania; Department of Medicine Surgery and Neuroscience University of Siena Siena Italy Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology Temple University Philadelphia Pennsylvania Department of Biology; College of Science and Technology; Temple University; Philadelphia Pennsylvania; Sbarro Institute for Cancer Research and Molecular Medicine; College of Science and Technology; Temple University; Philadelphia Pennsylvania Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Temple University, Philadelphia, Pennsylvania, USA Sbarro Health Research Organization, Philadelphia, PA, U.S.A. president@shro.org. Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. Department of Clinical and Molecular Medicine “Sapienza” University of Rome, Azienda Ospedaliera Sant'Andrea Rome Italy From the Department of Pathology Anatomy and Cell Biology (P.P.C., C.M.H., C.P., A.G.) and Kimmel Cancer Center (G.C.), Thomas Jefferson University, Philadelphia, Pa; Dipartimento di Scienze Odontostomatologiche e Maxillo-Facciali (P.P.C.), Universitá degli Studi di Napoli “Federico II,” Napoli, Italy; IRCCS “Neuromed” Institute (L.F., M.V., B.T.), Pozzilli (IS), Italy; Rangos Research Center (G.S.), University of Pittsburgh, Pittsburgh, Pa; Department of Surgical, Anatomical and Oncological... Department of Medicine, Surgery and Neuroscience University of Siena and Istituto Toscano Tumori (ITT) Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy asc Temple University, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology , Philadelphia , PA , USA. btb University of Siena, Department of Medicine, Surgery & Neuroscience, Siena, Italy. Department of Oncology, “Federico II” University, Italy Department of Medical Biotechnology, University of Siena, Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Temple University, Philadelphia, PA 19122, USA Department of Human Pathology and Oncology, University of Siena, Italy;; Sbarro Institute for Cancer Research and Molecular Medicine Center of Biotechnology, Temple University, Philadelphia, PA; Department of Medical Biotechnologies, University of Siena, Siena, Italia; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania; Department of Medical Biotechnologies, University of Siena, Siena, Italy Department of Medicine, Surgery and Neuroscience University of Siena and Istituto Toscano Tumori (ITT) Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine Center of Biotechnology, College of Science and Technology, Temple University BioLife Science Bldg. Suite 333, 1900N, 12th Street Philadelphia Pennsylvania 19122A; Department of Medicine Surgery and Neuroscience University of Siena Viale Bracci 16 53100 Siena Italy Departments of Pathology, Anatomy, and Cell Biology, and Sbarro Institute for Cancer Research and Molecular Medicine, Jefferson Medical College, Philadelphia, Pennsylvania; and Istituto di Tisiologia e Malattie Respiratorie “S. Marcatili,” Cattedra di Statistica Medica e Biometria, and Istituto di Anatomia e Istologia Patologica, Seconda Universita' degli Studi di Napoli, Naples, Italy 1Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania;; 2Department of Human Pathology and Oncology, University of Siena Nuovo Policlinico “Le Scotte,” Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, U.S.A. Department of Medicine, Surgery & Neuroscience, University of Siena, Siena, Italy. 1Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania;; 3Department of Human Pathology and Oncology, University of Siena, Italy; Department of Medicine Surgery and Neuroscience University of Siena Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine; Center for Biotechnology; College of Science and Technology; Temple University; Philadelphia, PA USA; Human Health Foundation; Terni and Spoleto, Perugia, Italy; Department of Human Pathology and Oncology; University of Siena; Siena, Italy; INT-CROM; Pascale Foundation; National Cancer Institute - Cancer Research Center; Mercogliano, Italy Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy Department of Medical Biotechnologies, University of Siena, Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Temple University, Philadelphia, PA 19122, USA ISOPROG-Somatolink EPFP Research Network, Philadelphia, PA, USA, Caltanissetta, Italy; School of Medical Biotechnology, University of Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology College of Science and Technology, Temple University, Philadelphia, PA, U.S.A; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy Department of Human Pathology and Oncology, University of Siena, Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA for the COVID-19 and Cancer Consortium (CCC19) Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology Temple University Philadelphia Pennsylvania; Department of Medicine Surgery and Neuroscience University of Siena Siena Italy Authors' Affiliation: 1Sbarro Health Research Organization, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania; 2Department of Surgery and Oncology, Section of Medical Oncology; and 3Department of Cellular and Developmental Biology, University of Palermo, Palermo, Italy; 4Department of Biomedical Sciences, Division of Biochemistry and Biophysics, National Institute of Biostructures and Biosystems, University of Sassari, Sassari, Italy; 5Human Pathology and Oncology Department, University of Siena, Siena, Italy; and 6Human Health Foundation, Spoleto, Italy; Authors' Affiliation: 1Sbarro Health Research Organization, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania; 2Department of Surgery and Oncology, Section of Medical Oncology; and 3Department of Cellular and Developmental Biology, University of Palermo, Palermo, Italy; 4Department of Biomedical Sciences, Division of Biochemistry and Biophysics, National Institute of Biostructures and Biosystems, University of Sassari, Sassari, Italy; 5Human Pathology and Oncology Department, University of Siena, Siena, Italy; and 6Human Health Foundation, Spoleto, Italy; Authors' Affiliation: 1Sbarro Health Research Organization, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania; 2Department of Surgery and Oncology, Section of Medical Oncology; and 3Department of Cellular and Developmental Biology, University of Palermo, Palermo, Italy; 4Department of Biomedical Sciences, Division of Biochemistry and Biophysics, National Institute of Biostructures and Biosystems, University of Sassari, Sassari, Italy; 5Human Pathology and Oncology Department, University of Siena, Siena, Italy; and 6Human Health Foundation, Spoleto, Italy Center for Study and Research on Obesity, LITA Vialba, L. Sacco Hospital, University of Milan, Via G.B. Grassi 74, 20157 Milan, Italy; Institute of Normal Human Morphology-Anatomy, University of Ancona, Via Tronto 10/A, 60020 Ancona, Italy; and Division of Biological Sciences and Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115 Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA Sbarro Institute for Cancer Research and Molecular Medicine College of Science and Technology Temple University BioLife Science Bldg. Philadelphia Pennsylvania; INT‐CROM “Pascale Foundation” National Cancer Institute‐Cancer Research Center Mercogliano (AV) Italy; Department of Medical and Surgical Sciences and Neurosciences University of Siena Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology, Temple University Philadelphia, Pennsylvania Section of Neuroscience and Cell Biology Department of Experimental and Clinical Medicine Marche Polytechnic University Ancona Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania USA Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine Department of Biology, College of Science and Technology Temple University Philadelphia Pennsylvania; Department of Medicine Surgery, and Neuroscience University of Siena Siena Italy Human Health Foundation, 06049 Spoleto, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA 19122; Human Pathology and Oncology Department, University of Siena, 53100 Siena, Italy Authors' Affiliations: 1Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University and T. Campanella Cancer Center, Catanzaro; 2Department of Medical Sciences University of Milan, Hematology 1, IRCCS Policlinico Foundation, Milan; 3Human Pathology and Oncology Department, University of Siena, Siena, Italy; 4Department of Medical Oncology, Dana-Farber Cancer Institute; 5Boston Veterans Administration Healthcare System, West Roxbury, Boston, Massachusetts; and 6Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania; Authors' Affiliations: 1Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University and T. Campanella Cancer Center, Catanzaro; 2Department of Medical Sciences University of Milan, Hematology 1, IRCCS Policlinico Foundation, Milan; 3Human Pathology and Oncology Department, University of Siena, Siena, Italy; 4Department of Medical Oncology, Dana-Farber Cancer Institute; 5Boston Veterans Administration Healthcare System, West Roxbury, Boston, Massachusetts; and 6Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania 1Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania; and Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology Temple University Philadelphia Pennsylvania; Department of Medicine Surgery and Neuroscience University of Siena Siena Italy Sbarro Research Institute, College of Science and Technology, Temple University, Philadelphia, PA 19122;; Department of Human Pathology and Oncology, University of Siena, 53100 Siena, Italy; From the Division of Pharmacology, Department of Biomedical Sciences and Biotechnologies (A.V., F.B., I.S., P.F.S., M.P.), University of Brescia, Brescia, Italy; the Center for Study and Research on Obesity, Department of Pharmacology, Chemotherapy and Medical Toxicology (A.V., M.D., P.B., M.O.C., E.N.), University of Milan, Milan, Italy; the Department of Pharmacology (G.F., A.C.), University of Florence, Florence, Italy; the Institute of Normal Human Morphology (A.F., A.G.), Marche Polytechnic... Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology Temple University Philadelphia Pennsylvania PA 19122 USA; Department of Medical Biotechnologies University of Siena Italy Department of Respiratory Diseases, University of Naples, Azienda Ospedaliera Monaldi, Naples, Italy; Department of Pathology, Anatomy, and Cell Biology, Jefferson Medical College, Sbarro Institute for Cancer Research and Molecular Medicine, Philadelphia, Pennsylvania; Department of Cardio-Thoracic Surgery, University of Vienna, Vienna, Austria; and Department of Anatomic Pathology, University of Naples, Naples, Italy Department of Experimental and Clinical Medicine University of Ancona (Università Politecnica delle Marche) Ancona Italy Sbarro Institute for Cancer Research and Molecular Medicine Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery & Neurosciences University of Siena Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, U.S.A. giordano@temple.edu. Deparment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. Department of Medical Biotechnology University of Siena Italy; Center for Biotechnology Sbarro Institute for Cancer Research and Molecular Medicine Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine; Center for Biotechnology; College of Science and Technology; Temple University; Philadelphia, PA USA; Human Pathology and Oncology Department; University of Siena; Siena, Italy Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, USA Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA 19122, USA; Department of Medicine, Surgery and Neuroscience, University of Siena, 53011 Siena, Italy Freeman Laboratory of Cancer Cell Biology, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724. Department of Medical, Surgery & Neurosciences University of Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology Temple University Philadelphia Pennsylvania Department of Human Pathology and Oncology, University of Siena, Strada delle Scotte 6, 53100 Siena Italy; Sbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology, Temple University Philadelphia PA USA Sbarro Institute for Cancer Research and Molecular Medicine e del Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia; Pennsylvania; Department of Medicine, Surgery and Neurosciences; University of Siena; Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine Department of Biology, College of Science and Technology, Temple University PA Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center of Biotechnology, Temple University, Philadelphia, PA 19122, USA; Department of Human Pathology and Oncology, University of Siena, Siena, 53100, Italy Sbarro Institute for Cancer Research and Molecular Medicine Center of Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, College of Science and Technology Temple University Philadelphia Pennsylvania USA Department of Medicine, Surgery and Neurosciences; University of Siena; Italy; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology; Temple University; Philadelphia Pennsylvania Università Politecnica delle Marche Ancona Italy Sbarro Institute for Cancer Research and Molecular MedicineCenter for BiotechnologyTemple UniversityPhiladelphiaPennsylvaniaUSA; Department of Human PathologyOncology University of SienaSiennaItaly; Human Health FoundationSpoletoItaly Endoscopy Unit, Department of Gastroenterology, Hospital Clínic of Barcelona, Carrer de Villarroel 170, 08036 Barcelona, Spain. Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy; Oncology Research Center of Mercogliano (CROM), Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione Giovanni Pascale”, IRCCS, Naples, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia PA, USA Sbarro Institute for Cancer Research and Molecular Medicine & Center for Biotechnology Temple University Philadelphia Pennsylvania General Directorate, University Polyclinic “Luigi Vanvitelli” (AG), Naples, Italy Human Health Foundation, Spoleto, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, USA Sbarro Institute for Cancer Research and Molecular Medicine Department of Biology Temple University Philadelphia Pennsylvania; Department of Medicine Surgery and Neuroscience University of Siena Siena Italy Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. agiordano@mdanderson.org Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA, USA Department of Medicine Surgery and Neuroscience University of Siena and Istituto Toscano Tumori (ITT) Siena Italy; Department of Biology Sbarro Institute for Cancer Research and Molecular Medicine College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine, Temple University Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery and Neuroscience University of Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, Pennsylvania.; Human Health Foundation, Spoleto, Perugia, Italy.; Human Pathology and Oncology, University of Siena, Italy. Sbarro Health Research Organization Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience “University of Siena” Siena Italy Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania; Department of Medicine Surgery and Neuroscience University of Siena Siena Italy a Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA; c Department of Human Pathology and Oncology, Laboratory of Biomedical Technology and Oncology, Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, PA, USA;; Department of Human Pathology and Oncology, University of Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, Temple University, Philadelphia, Pennsylvania, USA; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, College of Science and Technology Temple University Philadelphia Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, Pennsylvania, USA Department of Biotechnology, Temple University Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology Temple University Philadelphia Pennsylvania; Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology Temple University Philadelphia Pennsylvania Dipartimento di Scienze Farmaceutiche, Università di Pisa, via Bonanno 6, 56126 Pisa, Italy, Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania 19122, Dipartimento Farmaco Chimico Tecnologico, Universita‘ degli Studi di Siena, Via De Gasperi 2, 53100 Siena, Italy Departments of Pathology, Anatomy, and Cell Biology, Jefferson Medical College, Philadelphia, Pennsylvania Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology, Temple University, Philadelphia, Pennsylvania 19122, United States Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA; Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy Sbarro Institute for Cancer Research and Molecular Medicine Department of Biology Temple University Philadelphia Pennsylvania Department of Biology College of Science and Technology Temple University Philadelphia Pennsylvania; Sbarro Institute for Cancer Research and Molecular Medicine College of Science and Technology Temple University Philadelphia Pennsylvania 1Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University;; 2Department of Pathology and Laboratory Medicine, College of Medicine, Drexel University, Philadelphia, Pennsylvania; |
Incoming Links
Total number of triples: 933.